Cord Blood Transplantation

Cord Blood TransplantationOne of three foundations of blood-forming cells used in transplants are Cord Blood whereas the other two bases are bone marrow and peripheral blood stem cells. The inoculation of umbilical cord blood to re-establish an individual's own blood production system blocked by anticancer drugs, radiation therapy, or both. Human cryopreserved CD34+ cells from cord blood, bone marrow, and Mobilized blood. CD34+ cells differentiate into all other white blood cells. More Cells. Relevant Results. Types: Cells, Media, Assays. Cancers are often treated through somatic cell transplants, including peripheral blood, bone marrow, and rope blood transplants. The first successful cord blood transplant (CBT) was wiped out 1988 during a child with Fanconi Anemia. The theory of the learning is twofold unit umbilical cord blood transplantation in adults will relate to a one-year endurance rate of at least 40%.

  • Human Leukocyte Antigen (HLA) Matching
  • Graft-Versus-Host Disease
  • Diversity
  • Infectious Disease Transmission
  • Clinical Data
  • Engraftment
  • Research and Clinical Trials

Related Conference of Cord Blood Transplantation

January 24-25, 2022

2nd European Congress on Hematology

Prague, Czech Republic
January 27-28, 2022

2nd World Congress on Hematology and Genetic Blood Disorders

Prague, Czech Republic
March 14-15, 2022

20th World Hematology Congress

London, UK

Cord Blood Transplantation Conference Speakers

Recommended Sessions

Related Journals

Are you interested in